| Tms Neurohealth Florida Pllc | |
|
2963 Gulf To Bay Blvd Ste 250 Clearwater FL 33759-4255 | |
| (813) 749-4209 | |
| Not Available |
| Full Name | Tms Neurohealth Florida Pllc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 2963 Gulf To Bay Blvd Ste 250, Clearwater, Florida |
| Authorized Official Name and Position | Arman C Moshyedi (MEMBER) |
| Authorized Official Contact | 4169159100 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tms Neurohealth Florida Pllc 890 Yonge Street 7th Floor Toronto ON M4W3P-4 Ph: () - | Tms Neurohealth Florida Pllc 2963 Gulf To Bay Blvd Ste 250 Clearwater FL 33759-4255 Ph: (813) 749-4209 |
| NPI Number | 1073179123 |
|---|---|
| Provider Enumeration Date | 05/14/2019 |
| Last Update Date | 03/20/2024 |
| Certification Date | 03/20/2024 |
| Medicare PECOS PAC ID | 2163854175 |
|---|---|
| Medicare Enrollment ID | O20191113001400 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073179123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| 261Q00000X | Clinic/center | (* (Not Available)) | Secondary |
| Provider Name | Carlos Torrellas |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1245394832 PECOS PAC ID: 7810881992 Enrollment ID: I20040210000671 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Antonio I De Filippo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1346223658 PECOS PAC ID: 9234178088 Enrollment ID: I20050430000037 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | David Panting |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1801887823 PECOS PAC ID: 0840214508 Enrollment ID: I20060120000341 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Karen J Severson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1689787426 PECOS PAC ID: 0840364030 Enrollment ID: I20080806000401 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Lindsay A Israel Gaines |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1811182702 PECOS PAC ID: 8123167350 Enrollment ID: I20091202000052 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Maria D Del Sol |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1184793341 PECOS PAC ID: 5890837967 Enrollment ID: I20100127000940 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Megan Toufexis |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023020021 PECOS PAC ID: 4385839604 Enrollment ID: I20101112000301 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Anthony S Capozzi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1528163367 PECOS PAC ID: 5294766887 Enrollment ID: I20110317000507 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Stephanie Katz Lirio |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1558450817 PECOS PAC ID: 6406023175 Enrollment ID: I20120120000231 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Debra Barnett |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1609921543 PECOS PAC ID: 7911164975 Enrollment ID: I20120202000081 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Ajay Mayor |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023060100 PECOS PAC ID: 8820058480 Enrollment ID: I20121001000142 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Pamela D Drake |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1831230937 PECOS PAC ID: 2163680687 Enrollment ID: I20150825003233 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Allison L Kennel-besselieu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689044885 PECOS PAC ID: 9830490200 Enrollment ID: I20151209002236 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Jessica Green |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811300510 PECOS PAC ID: 2365725827 Enrollment ID: I20170207001058 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | David P Samuels |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1942333158 PECOS PAC ID: 7113814229 Enrollment ID: I20171115002005 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Stacy-ann Binns-brown |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1801188859 PECOS PAC ID: 8426312836 Enrollment ID: I20180511001641 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Dorit Morecraft |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093121998 PECOS PAC ID: 8426277211 Enrollment ID: I20181121001014 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Margaret Higgs |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1609102912 PECOS PAC ID: 6305278326 Enrollment ID: I20191113001690 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Carlos Alberto Rueda |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1366490195 PECOS PAC ID: 6103807607 Enrollment ID: I20191121000822 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Jacob Marion Poole |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1619498763 PECOS PAC ID: 8325304587 Enrollment ID: I20210723002605 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Nerilene Ballard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235801978 PECOS PAC ID: 2860881844 Enrollment ID: I20211112000856 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Mariela Padro |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1992023790 PECOS PAC ID: 0941452619 Enrollment ID: I20211206001306 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Margo Seymour |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194248443 PECOS PAC ID: 2668801796 Enrollment ID: I20211208002664 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Fanette Prospere |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760067268 PECOS PAC ID: 9739571001 Enrollment ID: I20220118001493 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Javier Cumerma |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346721610 PECOS PAC ID: 9032590799 Enrollment ID: I20220713001402 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Whitney Lingenfelter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679938377 PECOS PAC ID: 3577944891 Enrollment ID: I20220718003979 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Timothy Thomas Turscak |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104446780 PECOS PAC ID: 0547639593 Enrollment ID: I20221213002786 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Janella Cua |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639577422 PECOS PAC ID: 1456721414 Enrollment ID: I20230109000724 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Sheilah B Stephens |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336856418 PECOS PAC ID: 8628449840 Enrollment ID: I20230126002733 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Clay Grimes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245636471 PECOS PAC ID: 4981079159 Enrollment ID: I20230403000065 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Eric Malz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598795536 PECOS PAC ID: 6103891973 Enrollment ID: I20230608001677 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Shari Korday Moore |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1730675810 PECOS PAC ID: 6709235393 Enrollment ID: I20231207002520 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
| Provider Name | Ivonne Nicole Marriott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467236059 PECOS PAC ID: 1557714425 Enrollment ID: I20240126001876 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.
Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.
A new study has found that users of heroin have high levels of a brain chemical called hypocretin. This hypocretin leads to "wakefulness" among the users and understanding this could help patients with narcolepsy.
Medicaid recipients and health care providers cannot sue state officials to challenge cuts in Medicaid payments, even if such cuts compromise access to health care for poor people, the Obama administration has told the Supreme Court.
› Verified 4 days ago
Loredana Repetto Lcsw & Assoc Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2329 Sunset Point Road, Suite 203, Clearwater, FL 33765 Phone: 727-669-3911 Fax: 727-669-3813 | |
Empower, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2120 Range Rd, Clearwater, FL 33765 Phone: 727-410-8911 Fax: 727-223-8917 | |
Baycare Medical Group, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2995 Drew St Fl 2, Clearwater, FL 33759 Phone: 727-281-9065 | |
Bay Area Behavioral Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13575 58th St N, Suite 131, Clearwater, FL 33760 Phone: 813-689-8828 Fax: 813-689-8802 | |
Camelot Community Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4910 Creekside Dr, Suite D, Clearwater, FL 33760 Phone: 727-593-0003 Fax: 727-596-1713 | |
Renee Michaels Lcsw Cap Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2329 Sunset Point Rd, Suite 203, Clearwater, FL 33765 Phone: 727-669-3811 Fax: 727-669-3813 | |
Debbie A. Noe, Lmhc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2451 N Mcmullen Booth Rd, Clearwater, FL 33759 Phone: 727-542-8662 |